论文信息 - Ten‐year follow‐up after intense chemoimmunotherapy with Rituximab‐HyperCVAD alternating with Rituximab‐high dose methotrexate/cytarabine (R‐MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma - 字舞流文

Ten‐year follow‐up after intense chemoimmunotherapy with Rituximab‐HyperCVAD alternating with Rituximab‐high dose methotrexate/cytarabine (R‐MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma

Michael L. Wang | H. Kantarjian | P. Mclaughlin | F. Cabanillas | A. Younes | L. Kwak | Lei Feng | L. Fayad | A. Goy | F. Hagemeister | B. Pro | J. Romaguera | F. Samaniego | Maria Alma Rodriguez | K. Hartig | P. Weaver | Lei Feng | M. Rodriguez